We are live on
!
Find out more
AC
Armistice Capital Portfolio holdings
AUM
$5.62B
1-Year Est. Return
36.06%
This Fund
S&P 500
This Quarter
Est. Return
+0.63%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$6.11B
AUM Growth
+$207M
(+3.5%)
Cap. Flow
+$183M
Cap. Flow
% of AUM
2.99%
Top 10 Holdings %
Top 10 Hldgs %
49.09%
Holding
188
New
51
Increased
37
Reduced
33
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$72.8M |
| 2 |
AutoZone
AZO
|
+$70.8M |
| 3 |
Crocs
CROX
|
+$61M |
| 4 |
Ulta Beauty
ULTA
|
+$58.5M |
| 5 |
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
|
+$51.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Five Below
FIVE
|
+$67.4M |
| 2 |
PTC Therapeutics
PTCT
|
+$64.3M |
| 3 |
Enanta Pharmaceuticals
ENTA
|
+$61.2M |
| 4 |
Burlington
BURL
|
+$60.4M |
| 5 |
Ross Stores
ROST
|
+$42.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 42.67% |
| 2 | Consumer Discretionary | 7.86% |
| 3 | Consumer Staples | 7.27% |
| 4 | Technology | 5.96% |
| 5 | Communication Services | 1.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Lowe's Companies
LOW
$122B
| $17.8M | 0.29% |
68,900
-127,522
| -65% | -$30.3M |
|
77
BioNTech
BNTX
$23.1B
| $17.5M | 0.29% |
68,000
+16,000
| +31% | +$4.38M |
|
|
KDNY
78
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $16.9M | 0.28% |
1,036,000
-188,000
| -15% | -$2.68M |
|
79
Cisco
CSCO
$480B
| $16.5M | 0.27% |
+261,000
| New | +$14.9M |
|
80
Atlassian
TEAM
$28B
| $16.4M | 0.27% |
+43,000
| New | +$17.3M |
|
81
Datadog
DDOG
$103B
| $16.2M | 0.27% |
+91,000
| New | +$15.4M |
|
82
Thermo Fisher Scientific
TMO
$209B
| $16M | 0.26% |
24,000
-36,000
| -60% | -$22.5M |
|
83
Advantage Solutions
ADV
$555M
| $15.2M | 0.25% |
75,840
+960
| +1% | +$197K |
|
84
RingCentral
RNG
$5.09B
| $14.8M | 0.24% |
79,000
+29,000
| +58% | +$6.44M |
|
|
GTM
85
ZoomInfo Technologies
GTM
$1.07B
| $14.4M | 0.24% |
+225,000
| New | +$15.1M |
|
86
Lamb Weston
LW
$7.31B
| $14.2M | 0.23% |
224,000
-132,000
| -37% | -$7.62M |
|
87
Meta Platforms (Facebook)
META
$1.5T
| $13.5M | 0.22% |
40,000
-64,000
| -62% | -$21.2M |
|
|
ZEN
88
DELISTED
ZENDESK INC
ZEN
| $13.3M | 0.22% |
+128,000
| New | +$13.7M |
|
|
SPPI
89
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $12.3M | 0.2% |
9,665,756
-6,734,244
| -41% | -$12M |
|
90
SAP
SAP
$226B
| $11.8M | 0.19% |
+84,000
| New | +$11.7M |
|
|
SMAR
91
DELISTED
Smartsheet Inc.
SMAR
| $11.6M | 0.19% |
+150,000
| New | +$10.5M |
|
92
American Eagle Outfitters
AEO
$3.03B
| $10.4M | 0.17% |
+408,878
| New | +$10.4M |
|
93
FIVE9
FIVN
$2.28B
| $10.3M | 0.17% |
+75,000
| New | +$11.1M |
|
|
CFLT
94
DELISTED
Confluent
CFLT
| $9.45M | 0.15% |
+124,000
| New | +$8.94M |
|
95
Cloudflare
NET
$107B
| $9.07M | 0.15% |
+69,000
| New | +$11.6M |
|
96
Nomad Foods
NOMD
$1.66B
| $9.04M | 0.15% |
+356,000
| New | +$9.19M |
|
97
Paycom
PAYC
$8.17B
| $8.72M | 0.14% |
+21,000
| New | +$9.94M |
|
|
AMYT
98
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
| $8.64M | 0.14% |
800,000
+176,000
| +28% | +$1.9M |
|
99
Dynatrace
DT
$13.3B
| $8.45M | 0.14% |
+140,000
| New | +$9.54M |
|
100
Williams-Sonoma
WSM
$29.3B
| $6.99M | 0.11% |
82,676
-68,908
| -45% | -$6.42M |
|
Similar funds
CRC
RMDI
F
EW
O
PA
DSC
ACM
Armistice Capital's Q4 2021 Portfolio in Review
As of Q4 2021, Armistice Capital held 188 positions worth $6.11B, up 3.5% from $5.9B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Armistice Capital's Q4 2021 filing shows 51 new, 37 increased, 33 reduced and 43 closed positions. Its largest new stake was AutoZone: 38,024 shares worth $79.7M. The largest sale was Five Below, an estimated $67.4M.
By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 45% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.
- Armistice Capital's largest Q4 2021 buy was AutoZone: 38,024 shares worth $79.7M.
- Armistice Capital added most to Jazz Pharmaceuticals in Q4 2021, an estimated $72.8M increase.
- Armistice Capital's biggest Q4 2021 reduction was PTC Therapeutics, cutting an estimated $64.3M.
- Armistice Capital fully exited Five Below in Q4 2021, selling an estimated $67.4M.
- Armistice Capital's ten largest holdings make up 49% of its $6.11B portfolio in Q4 2021.
- Armistice Capital opened 51 new positions and closed 43 in Q4 2021.
- Armistice Capital's portfolio value rose 3.5% quarter-over-quarter to $6.11B.
Based on Armistice Capital's 13F filing for Q4 2021, filed 14 Feb 2022.